Are People With Chronic Kidney Disease Being Excluded From Clinical Trials and Access to New Therapies?

Major European and international kidney associations have joined in an awareness campaign to stress the urgent need to include patients with chronic kidney disease in clinical trials. In a recent…

Continue Reading Are People With Chronic Kidney Disease Being Excluded From Clinical Trials and Access to New Therapies?
Study Suggests Russian Healthcare Providers May Be Critically Uninformed About Fabry Disease
opsa / Pixabay

Study Suggests Russian Healthcare Providers May Be Critically Uninformed About Fabry Disease

According to a publication from Fabry Disease News, Russian researchers recently screened over five-and-a-half thousand patients for Fabry disease while they continued with prescribed hemodialysis. The researchers' study, published in…

Continue Reading Study Suggests Russian Healthcare Providers May Be Critically Uninformed About Fabry Disease
Drug Shows Potential in Treating Hyperkalemia Associated With End-Stage Kidney Disease
jarmoluk / Pixabay

Drug Shows Potential in Treating Hyperkalemia Associated With End-Stage Kidney Disease

According to a story from BioPortfolio, the biopharmaceutical company AstraZeneca recently announced the release of positive results from a phase 3b clinical trial. This trial was testing the safety and…

Continue Reading Drug Shows Potential in Treating Hyperkalemia Associated With End-Stage Kidney Disease
First Patient Enrolled in Phase 3 Trial for Autosomal Dominant Polycystic Kidney Disease
Free-Photos / Pixabay

First Patient Enrolled in Phase 3 Trial for Autosomal Dominant Polycystic Kidney Disease

Do you have ADPKD? If you or someone you know has ADPKD, email us at Contribute@patientworthy.com. We'd love to hear from you about your experience! According to a story from…

Continue Reading First Patient Enrolled in Phase 3 Trial for Autosomal Dominant Polycystic Kidney Disease

The FDA is Reversing Course on Unapproved Products Sold by Stem Cell Manufacturers

  The FDA’s “untitled letter” to R3 Stem Cell (R3), based in Scottsdale Arizona, cautioned R3 that the product they are marketing is considered a drug. It must, therefore, be…

Continue Reading The FDA is Reversing Course on Unapproved Products Sold by Stem Cell Manufacturers
Improvements in Treatment Access are Helping Indigenous Chronic Kidney Disease Patients, but More Changes are Needed
1662222 / Pixabay

Improvements in Treatment Access are Helping Indigenous Chronic Kidney Disease Patients, but More Changes are Needed

According to a story from abc.net.au, the local health services from northwest Queensland, Australia have recently been tasked with managing dialysis treatment centers in the region. This has improved access…

Continue Reading Improvements in Treatment Access are Helping Indigenous Chronic Kidney Disease Patients, but More Changes are Needed
Funding Goal Achieved for Pulmonary Arterial Hypertension Clinical Trial
jarmoluk / Pixabay

Funding Goal Achieved for Pulmonary Arterial Hypertension Clinical Trial

According to a story from Euroinvestor, the drug development company Resverlogix Corp. recently announced that it has received the necessary $2.9 million in funding for a Phase 2 clinical trial…

Continue Reading Funding Goal Achieved for Pulmonary Arterial Hypertension Clinical Trial

Yet Another Study Shows the Dire Need for More Diversity in Medical Research

A recent study published in Cell has exhibited the scientific community's negligence for conducting research that includes an adequate representation of non-Europeans. Specifically, it showed that 78% of patients in genomic…

Continue Reading Yet Another Study Shows the Dire Need for More Diversity in Medical Research

Biotech Companies are Increasingly Focused on Deadly Diseases With Significant Unmet Need

According to a story from finanznachrichten.de, biotechnology companies are starting to set their sights on treating deadly diseases that are lacking effective treatment options, including some diseases that are considered…

Continue Reading Biotech Companies are Increasingly Focused on Deadly Diseases With Significant Unmet Need

Study Shows Distal Renal Tubular Acidosis Patient Outcomes Vary Across Country Lines

What is Distal Renal Tubular Acidosis? Distal renal tubular acidosis (dRTA) is a rare condition which affects approximately 1 in every 100,000 people worldwide. It is caused by a build up…

Continue Reading Study Shows Distal Renal Tubular Acidosis Patient Outcomes Vary Across Country Lines

Study Shows Treatment may be Effective for Chronic Kidney Disease but Increase Risk of Hyperkalemia

A recent study, called TOPCAT, evaluated the effects of spironolactone as a treatment for individuals living with Chronic Kidney Disease (CKD) who are also diagnosed with heart failure with preserved ejection fraction,…

Continue Reading Study Shows Treatment may be Effective for Chronic Kidney Disease but Increase Risk of Hyperkalemia
Computer Simulation Shows Surgery is Overprescribed for Kidney Cancer Patients
source: pixabay.com

Computer Simulation Shows Surgery is Overprescribed for Kidney Cancer Patients

The most common treatment for someone who is discovered to have early stage kidney cancer is surgery. The patient's tumors and a part of their kidneys are removed through a…

Continue Reading Computer Simulation Shows Surgery is Overprescribed for Kidney Cancer Patients